$REE

REE Automotive Announces a Supplement to its Proxy Statement for its Special General Meeting of Shareholders to be held on November 13, 2025 - REE Automotive (NASDAQ:REE)

TEL AVIV, Israel, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- REE Automotive Ltd. ( NASDAQ:REE ) ( "REE" ) , an automotive technology company developing software-defined vehicle technology, today announced the release of a supplement ( the "Supplement" ) to its proxy statement dated October 9, 2025 ( ...

Original reporting
Benzinga · Globe Newswire
Published Nov 11, 2025, 10:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2025, 11:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$REE
Bullish
medium confidence
Mentioned
$REE
Relevance
6/10
AlphAI data visualization · based on Benzinga
Decision brief

The 30-second read

$REEBullishMed
01

Why it matters

The supplement to the proxy statement suggests ongoing corporate governance activities, which could enhance investor confidence and support stock price stability or growth.

02

Market read

The news is relevant for investors interested in EV technology and automotive innovation sectors, with potential to influence short-term trading decisions.

03

What to watch

Market conditions, broader EV sector performance, and macroeconomic factors could overshadow company-specific news.

Relevance 6/10Timing: short-term (within 1-2 trading days)

Background

REE Automotive is developing software-defined vehicle technology, aiming to innovate in the EV commercial vehicle segment.

Company-level read

Ticker impact

$REEBullishMedium confidence
Context

Primary focus due to recent proxy statement supplement and bullish sentiment.

Expected impact

Potential short-term increase of 2-4% in REE stock price following news release.

Evidence & confidence

Corporate governance updates often signal stability and strategic focus, but the direct impact on stock price depends on investor perception and market conditions.

Market effects

The news may reinforce positive sentiment in the automotive technology sector, especially among EV and software-defined vehicle companies.

Limited regional impact; primarily relevant to US and Israeli markets.

Moderate; as REE is a NASDAQ-listed company, developments may influence global EV technology investor sentiment.

Counterpoint

Some investors may view the proxy statement supplement as routine and not indicative of material positive developments, thus limiting upside potential.

Key entities

  • REE Automotive Ltd.

    An automotive technology company focusing on software-defined vehicles.

  • NASDAQ

    The stock exchange where REE is listed.

Related articles

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$FWRDMed

Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship

FORWARD AIR CORP (FWRD) filed an SEC Form 8-K — Other Events. Forward Air Announces Two-Year Definitive Agreement to Retain Significant Portion of Previously Disclosed Customer Relationship 2026 to 2028 Forecasted Annual Revenue from Customer Expected to Exceed 2025 Revenue Driven by Growth in Retained Services DALLAS – October 28, 2026 – F

$PYPDMedAI 8/10

PolyPid unveils PD01B for diabetic foot infection treatment

PolyPid Ltd. (NASDAQ:PYPD) introduced PD01B, a product candidate for treating moderate to severe diabetic foot infections, using its Kynatrix delivery technology. The company plans to initiate a first-in-human study in the second half of 2027. PolyPid also expects a decision on its lead product D-PLEX₁₀₀ by November 28, 2026, with a potential U.S. launch in early 2027, subject to FDA approval.

$KTOSMed

Kratos wins $33.6 million NASA power system contract

Kratos Defense & Security Solutions (KTOS) won a $33.6M contract from NASA to design and build a power system for the Space Reactor-1 Freedom spacecraft, launching in 2028. Kratos will work as a subcontractor to Sierra Lobo under NASA’s SpaceDOC III contract, providing a power conversion system for the mission to Mars. The spacecraft aims to demonstrate nuclear electric propulsion technology. According to the company, the contract is a significant milestone in advancing space nuclear propulsion.